These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27932515)

  • 1. Genotoxic effect of iron overload and disease complications in transfused β thalassaemic patients.
    Ferro E; Visalli G; La Rosa MA; Piraino B; Civa R; Randazzo Papa G; Di Pietro A
    Mutagenesis; 2017 Mar; 32(2):275-281. PubMed ID: 27932515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients.
    Ferro E; Visalli G; La Rosa MA; Civa R; Papa GR; D'Ascola DG; Roccamo G; Piraino B; Salpietro C; Di Pietro A
    Hematology; 2017 Apr; 22(3):183-191. PubMed ID: 27801288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects.
    Ferro E; Visalli G; Civa R; La Rosa MA; Randazzo Papa G; Baluce B; D'Ascola DG; Piraino B; Salpietro C; Di Pietro A
    Free Radic Biol Med; 2012 Nov; 53(10):1829-37. PubMed ID: 22995637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble hemojuvelin in transfused and untransfused thalassaemic subjects.
    Ferro E; Di Pietro A; Visalli G; Piraino B; Salpietro C; La Rosa MA
    Eur J Haematol; 2017 Jan; 98(1):67-74. PubMed ID: 27440164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
    Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
    Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
    Prati D
    Vox Sang; 2000; 79(3):129-37. PubMed ID: 11111230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
    Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
    Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine complications in patients with Thalassaemia Major.
    Toumba M; Sergis A; Kanaris C; Skordis N
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
    Christoforidis A; Haritandi A; Perifanis V; Tsatra I; Athanassiou-Metaxa M; Dimitriadis AS
    Eur J Radiol; 2007 Apr; 62(1):138-42. PubMed ID: 17161570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spermatozoal DNA damage in patients with B thalassaemia syndromes.
    De Sanctis V; Perera D; Katz M; Fortini M; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():185-9. PubMed ID: 19337176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study.
    Chapchap EC; Silva MMA; de Assis RA; Kerbauy LN; Diniz MDS; Rosemberg LA; Loggetto SR; Araujo ADS; Fabron Junior A; Verissimo MPA; Baldanzi GR; Esposito BP; Tricta F; Steagall MEA; Vellozo CÂGDS; Fertrin KY; Baroni RH; Hamerschlak N
    Hematol Transfus Cell Ther; 2023; 45(1):7-15. PubMed ID: 34090847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of iron salts and haemosiderin from a thalassaemia patient on oxygen radical damage as measured in the comet assay.
    Anderson D; Yardley-Jones A; Hambly RJ; Vives-Bauza C; Smykatz-Kloss V; Chua-Anusorn W; Webb J
    Teratog Carcinog Mutagen; 2000; 20(1):11-26. PubMed ID: 10607374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant micronutrients in children with thalassaemia in Egypt.
    Nasr MR; Ali S; Shaker M; Elgabry E
    East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.
    Roghi A; Cappellini MD; Wood JC; Musallam KM; Patrizia P; Fasulo MR; Cesaretti C; Taher AT
    Ann Hematol; 2010 Jun; 89(6):585-9. PubMed ID: 20016898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.